The angiogenic response to skeletal injury is preserved in the elderly.
Angiogenesis is essential for normal bone formation and repair. Avascularity characterizes aberrant fracture union in the elderly, while angiogenic mechanisms during cutaneous wound repair are attenuated in aged humans. We hypothesized that skeletal injury results in local (circulating) and systemic (fracture site) 'angiogenic' responses and that these reparative mechanisms are attenuated with advanced patient age. This prospective study examined peripheral blood and fracture hematoma from 32 patients, 16 under 40 years and 16 over the age of 75, undergoing emergent surgery for isolated fracture. The angiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor (PDGF) were assayed. Endothelial cell cultures were supplemented with patient plasma and fracture hematoma and angiogenesis determined in vitro by measuring cell proliferation and blood vessel tube formation. Angiogenesis was determined in vivo using a murine dorsal wound pocket model and quantification of new blood vessel formation after 7 days. We found that all injured patients, irrespective of age, have elevated plasma and fracture hematoma levels of VEGF and PDGF. These elevated cytokine concentrations translate into biologically significant angiogenic effects, in vitro and in vivo. These effects are primarily VEGF mediated and are not dependent on patient age. The biological activity of these growth factors does not diminish with advanced age. Thus skeletal injury does result in local and systemic angiogenic responses whereby angiogenic cytokine availability and activity is preserved in the aged suggesting alternative mechanisms for the development of avascularity in delayed and fracture non-union in the elderly.
Street
J T
JT
Department of Academic Surgery, National Univesity of Ireland, Cork. hrb_street@yahoo.com
Wang
J H
JH
Wu
Q D
QD
Wakai
A
A
McGuinness
A
A
Redmond
H P
HP
D000328:Adult; D000368:Aged; D000375:Aging / Q000502:physiology; D002455:Cell Division; D016228:Endothelial Growth Factors / Q000097:blood / Q000502:physiology; D004730:Endothelium, Vascular / Q000166:cytology; D005260:Female; D050723:Fractures, Bone / Q000097:blood / Q000503:physiopathology*; D006406:Hematoma / Q000378:metabolism; D006801:Humans; D008222:Lymphokines / Q000097:blood / Q000502:physiology; D008297:Male; D008875:Middle Aged; D018919:Neovascularization, Physiologic; D010982:Platelet-Derived Growth Factor / Q000032:analysis / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D010982:Platelet-Derived Growth Factor; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors